Careside Announces Distribution Agreements, Completion of Sales Training.Business Editors and Health/Medical Writers CULVER CITY, Calif.--(BW HealthWire)--June 21, 2001 Careside Inc. (AMEX AMEX See: American Stock Exchange :CSA (1) (Canadian Standards Association, Toronto, Ontario, www.csa.ca) A standards-defining organization founded in 1919. It is involved in many industries, including electronics, communications and information technology. ) Thursday announced new distribution agreements with three distributors of medical and laboratory supplies: Alaska Scientific Inc., Kern Surgical Supply Inc. and Hankins Surgical Supply Co. "These are the latest of several agreements that have greatly increased Careside's reach into the physician office lab market," said W. Vickery Stoughton, Careside's chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "As our distribution network expands, we expect that demand for our point-of-care testing point-of-care testing Lab medicine The analysis of clinical specimens as close as possible to the Pt, including bedside, ward–unit, or 'stat' regional response labs that service specified areas–eg, the ER or ICU instruments in the physician market will continue to grow." Careside's sales representatives will work closely with the distributors' sales forces to sell Careside products to physicians with in-office laboratories, physicians planning to set up laboratories, and other purchasers of point-of-care testing equipment. In another development, Careside also announced that 70 sales representatives from the Primary Care and Acute Care divisions of Fisher HealthCare recently completed sales training on the Careside System. Earlier this year, Careside announced a national distribution agreement with the company, an operating unit operating unit A type of operating company that engages in transactions with outsiders and that is owned by another business. For example, in 1995 the stockholders of Capital Cities/ABC approved a $19 billion merger with the Walt Disney Company, whereupon of Fisher Scientific International Inc. Fisher Healthcare provides clinical and diagnostic products to physicians' office laboratories as well as hospitals, and independent and government health systems. Careside, a leader in point-of-care (POC (Proof Of Concept) See PoC exploit. POC - Point Of Contact ) testing technology, manufactures the Careside System, which includes two industry-leading desktop instruments, the Careside Analyzer and Careside H-2000, and a data manager, Careside Connect. The Careside System combines quick, comprehensive POC blood testing with universal data management. About Careside's New Distribution Partners Based in Bakersfield, Calif. since 1961, Kern Surgical Supply is a leading medical supplier in central California. For more about the company, access www.kernsurgical.com. Medical laboratory supply company Alaska Scientific Inc. serves the entire state of Alaska from its home base in Anchorage. Its primary customers are hospitals and physician laboratories. For more about the company, access www.alaskascientific.net. Hankins Surgical Supply Co. of Springfield, Mo. distributes medical and lab supplies primarily to the physician office marketplace. Its region of operation includes Northern Arkansas, Southeast Kansas, Northeastern Oklahoma, and Southwest Missouri. For more about the company, call 417/869-2549. About Careside's Technology Representing a major advance in physician office lab testing, the Careside Analyzer(R) offers the broadest test menu available today on one POC device: 41 FDA-cleared or exempt tests in the categories of chemistry, electrochemistry electrochemistry, science dealing with the relationship between electricity and chemical changes. Of principal interest are the reactions that take place between electrodes and the electrolytes in electric and electrolytic cells (see electrolysis), as well as the and coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or . These tests can be completed in just four to 12 minutes. In last year's national Medical Design Excellence Awards competition, the Careside Analyzer took top honors in the In Vitro Diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. category. The companion Careside H-2000, a hematology unit, yields precise 16-or 18-parameter complete blood counts within two minutes. The data management component, the groundbreaking Careside Connect, collects and translates data, in real time, from any medical device that has an active serial port. No other portable, fully automatic, plug-and-play data manager is so affordable to physicians in solo or small group practices. The Careside System provides data in both print and electronic formats, including most of the data required for compliance with the Clinical Laboratory Improvement Amendments Clinical Laboratory Improvement Amendments (CLIA) of 1988 are United States federal regulatory standards that apply to all clinical laboratory testing performed on humans in the United States, except clinical trials and basic research. (CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a ). This is unique in the POC field. For more information on Careside, Inc., call toll-free 888/698-2273 or access www.Careside.com. Safe Harbor: Statements in this press release regarding Careside Inc. that are not historical facts are forward-looking statements that involve risks and uncertainties. Such forward-looking statements include the company's anticipated effects of the distribution agreements. Key factors that may affect these statements include technological hurdles and other challenges inherent in product research, development, manufacturing, marketing and other factors discussed in the company's prospectus. The company undertakes no obligation to update forward-looking statements. See the risk factors list. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion